Abstract
Several studies have been demonstrated the value of c-ErbB-2 and Bcl-2 in predicting the biological behaviour of tumors. The aim of this study was to investigate Bcl-2 and c-ErbB-2 expression in colorectal carcinomas and the correlation between their presence and other clinicopathologic parameters. Eighty-six colorectal carcinomas and 17 adenomas were stained with Bcl-2 and c-ErbB-2 immunohistochemically. Staining patterns were assessed semiquantitatively and correlated with tumor size, Duke’s classification, tumor differentiation, mucinous characteristic and anatomic locations. We detected Bcl-2 expression in 10 of 17 adenomas (58.8 %) and 31 of 86 carcinomas (36.04 %). Positive staining in normal mucosa was observed only in the compartment of cryptic cells. However neither the difference in the rates of Bcl-2 positivity in adenoma and carcinoma groups, nor the correlation with other mentioned clinicopathological parameters, were found statistically significant. Bcl-2 expression was found to be significantly high in mucinous carcinomas. Expression of c-ErbB-2 was observed in 12 of 86 (13.95 %) carcinomas. It was not detected in adenomas and normal mucosa. Although the incidence of c-ErbB-2 in nonmucinous carcinoma was higher than that of mucinous carcinoma, this was not significant. In addition we were unable to show any significant relation between c-ErbB-2 expression and other clinicopathologic features. Our result suggest that c-ErbB-2 protein expression in colorectal carcinomas, is not very frequent event. There is no correlation between c-ErbB-2 expression and malignant potential of colorectal carcinomas. Higher expressions of Bcl-2 in adenomas than carcinomas suggest us a possible role of Bcl-2 in early carcinogenesis of colon. However since we were unable to find any significant correlation between Bcl-2 expression and other parameters the impact of this gene on biological behavior is still unclear for us.
Similar content being viewed by others
References
Baretton GB, Diebold J, Christoforis, et al: Apoptosis and immunohistochemical Bcl-2 expression in colorectal adenomas and carcinomas. Cancer 77:255–264, 1996.
Bedi A, Pasricha PJ, Akhtar AJ, et al: Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1811–1816, 1995.
Bosari S, Viale G, Bossi P, et al: Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86:681–687, 1994.
Bronner MP, Culm C, Reed JC, et al: The Bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146:20–26, 1995.
Fearon ER, Vogelstein B: A genetic model of colorectal carcinogenesis. Cell 61:759–767, 1990.
Gorczyca W, Makiewski M, Kram A, et al: Immunohistochemical analysis of Bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virhows Arch 420:229–233, 1995.
Hao XP, Ilyas M, Talbot IC, et al: Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence. Pathobiology 65:140–145, 1997.
Kapitanovic S, Spaventi R, Poljak L, et al: High c-Erb B-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detection and Prevention 18:97–101, 1994.
Kapitanovic S, Radosevic S, Kapitanovic M, et al: The Expression of p185HER-2/neu Correlates With the Stage of Disease and Survival in Colorectal Cancer. Gastroenterology 112:1103–1111, 1997.
Lauwers GY, Scott GV, Hendricks J: Immunohistochemical evidence of aberrant Bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73:2900–2904, 1994.
Manne U, Myers BR, Moron C, et al: Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer (Pred. Oncol.) 74:346–358, 1997.
Menard S, Tagliabue E, Campiglio M, et al: Role of HER2 Gene Overexpression in Breast Carcinoma. J Cell Physol 182:150–162, 2000.
Müller-Höcker J: Immunreactivity of p53, Ki67 and Bcl-2 in oncocytic adenomas and carcinomas of the throid gland. Hum Pathol 30:926–933, 1999.
Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol. 124:1–6, 1993.
Tollenaar R, Krieken JHJM, Slooten HV, et al: Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 77:1842–1847, 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dursun, A., Poyraz, A., Süer, Ö. et al. Expression of Bcl-2 and c-ErbB-2 in colorectal neoplasia. Pathol. Oncol. Res. 7, 24–27 (2001). https://doi.org/10.1007/BF03032600
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032600